[Chemoradiotherapy for advanced head and neck cancer - patient survival is more important than reduced toxicity]. / Chemoradiotherapie bei fortgeschrittenen Kopf-Hals-Tumoren - Überlebensvorteil ist Patienten wichtiger als verminderte Toxizität.
Laryngorhinootologie
; 92(9): 580-1, 2013 Sep.
Article
in De
| MEDLINE
| ID: mdl-24137786
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Carcinoma, Squamous Cell
/
Oropharyngeal Neoplasms
/
Cisplatin
/
Chemoradiotherapy
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Male
Language:
De
Journal:
Laryngorhinootologie
Journal subject:
OTORRINOLARINGOLOGIA
Year:
2013
Document type:
Article
Affiliation country:
Germany
